Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

5.6K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
5.6K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

41.6K
Overview
41.6K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

13.8K
13.8K
Epigenetic Regulation01:37

Epigenetic Regulation

4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
Epigenetic Regulation01:46

Epigenetic Regulation

34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Genome Copying Errors02:46

Genome Copying Errors

5.3K
DNA replication is a well-evolved process that copies millions of base pairs with high fidelity during each cell division. Occasionally a wrong base or a long stretch of wrong bases may get added to the daughter strands. If the errors are left unchecked, cells might accumulate several mutations that might endanger their  survival. Therefore, the copying errors are checked and repaired at three levels.
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

APOBEC2 deficiency disrupts hematopoietic lineage commitment, resulting in emergence of dual identity lymphocytes in mice and humans.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

DGAT1 mediates sex-specific CD8<sup>+</sup> T cell antitumour responses.

Nature metabolism·2026
Same author

The two-step purification method ViREn identifies a single NSUN6-mediated 5-methylcytosine modification promoting dengue virus RNA genome turnover.

Nucleic acids research·2026
Same author

3'-end ligation sequencing is a sensitive method to detect DNA nicks at potential sites of off-target activity induced by prime editors.

Genome research·2025
Same author

Circulating tumor-reactive KIR<sup>+</sup>CD8<sup>+</sup> T cells suppress anti-tumor immunity in patients with melanoma.

Nature immunology·2024
Same author

APOBEC2 safeguards skeletal muscle cell fate through binding chromatin and regulating transcription of non-muscle genes during myoblast differentiation.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same journal

Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers.

Trends in cancer·2026
Same journal

Patient-derived organoids in hematologic malignancies: Fidelity and translation beyond animals.

Trends in cancer·2026
Same journal

Precision neuro-oncology for children: Time to gear up!

Trends in cancer·2026
Same journal

Multi-omics analysis of extracellular vesicle cargo in cancer.

Trends in cancer·2026
Same journal

An immunological panacea for cancer-related cachexia.

Trends in cancer·2026
Same journal

Beyond one gene, one target: Next-generation precision oncology.

Trends in cancer·2026
See all related articles

Related Experiment Video

Updated: Mar 14, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.4K

RNA Editing Dynamically Rewrites the Cancer Code.

Violeta Rayon-Estrada1, F Nina Papavasiliou2, Dewi Harjanto2

  • 1Laboratory of Lymphocyte Biology, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA; The Rockefeller Graduate Program, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA.

Trends in Cancer
|October 4, 2016
PubMed
Summary
This summary is machine-generated.

Adenosine deaminase, RNA-specific (ADAR)-mediated RNA editing is common in cancer, affecting key genetic sites. Elevated ADAR activity correlates with cancer progression, suggesting ADAR and edited transcripts as potential therapeutic targets.

More Related Videos

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

6.0K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

8.5K

Related Experiment Videos

Last Updated: Mar 14, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.4K
Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

6.0K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

8.5K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • RNA editing, particularly adenosine-to-inosine (A-to-I) changes mediated by ADAR enzymes, is increasingly recognized in various biological processes.
  • Aberrant RNA editing has been implicated in the development and progression of numerous diseases, including cancer.

Purpose of the Study:

  • To investigate the role and significance of ADAR-mediated RNA editing in the context of human cancer transcriptomes.
  • To explore the correlation between RNA editing patterns and cancer progression and prognosis.

Main Methods:

  • Global analysis of cancer transcriptomes.
  • Identification and quantification of ADAR-mediated RNA editing events across diverse cancer types.
  • Correlation analysis between editing levels and clinical parameters such as cancer progression and patient prognosis.

Main Results:

  • ADAR-mediated RNA editing is a dynamic process contributing to genetic alterations in cancer.
  • The abundance and frequency of RNA editing are elevated in cancer.
  • Editing events affect functionally and clinically relevant sites in both coding and non-coding RNA regions.

Conclusions:

  • ADAR-mediated RNA editing plays a significant role in cancer development and progression.
  • Differentially edited transcripts and ADAR itself represent promising biomarkers for cancer diagnosis and prognosis.
  • ADAR and its edited targets hold potential as novel therapeutic targets for cancer treatment.